stage II ovarian epithelial cancer
Showing 1 - 25 of >10,000
Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)
Not yet recruiting
- Ovarian Cancer
- Carboplatin
- olaparibp, embro
-
Birmingham, AlabamaO'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023
Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)
Not yet recruiting
- Ovarian Cancer
- +3 more
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jul 18, 2023
Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)
Recruiting
- Stage III Ovarian Cancer
- +6 more
- Cytoreductive Surgery (CRS)
- +6 more
-
Baltimore, MarylandMercy Medical Center
Aug 30, 2022
Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal Carcinoma Trial in Italy (carboplatin and paclitaxel followed by surgery)
Active, not recruiting
- Ovarian Cancer
- +2 more
- carboplatin and paclitaxel followed by surgery
-
Bologna, Italy
- +4 more
Dec 28, 2022
Ovarian Cancer Trial in Shanghai (Etoposide, Cyclophosphamide, Carboplatin)
Active, not recruiting
- Ovarian Cancer
- Etoposide, Cyclophosphamide, Carboplatin
-
Shanghai, Shanghai, ChinaWu Xiaohua
Jul 25, 2022
Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)
Suspended
- Brenner Tumor
- +27 more
- metformin hydrochloride
- +2 more
-
Birmingham, Alabama
- +9 more
May 16, 2022
Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer Trial in United States (Mind-body resilience training, Music therapy,
Recruiting
- Ovarian Cancer
- +13 more
- Mind-body resilience training
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Jun 28, 2022
Fallopian Tube Cancer, Peritoneum Cancer, Epithelial Ovarian Cancer Trial in Miami (Pembrolizumab, Paclitaxel, Carboplatin)
Recruiting
- Fallopian Tube Cancer
- +2 more
- Pembrolizumab
- +2 more
-
Miami, FloridaUniversity of Miami
Dec 24, 2021
Developing a Test for the Detection of Ovarian Cancer
Recruiting
- Ovarian Neoplasms
- +14 more
- Uterine lavage, or a wash of the womb
- +2 more
-
Little Rock, Arkansas
- +5 more
Apr 29, 2022
Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,
Recruiting
- Advanced Fallopian Tube Carcinoma
- +21 more
- Biopsy
- +2 more
-
Bethesda, Maryland
- +2 more
Jan 25, 2023
Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal
Not yet recruiting
- Platinum-Resistant Fallopian Tube Carcinoma
- +6 more
- Biopsy
- Pegylated SN-38 Conjugate PLX038
-
Rochester, MinnesotaMayo Clinic
Jul 19, 2022
Ovarian Cancer Trial in Milwaukee (Pembrolizumab, Carboplatin, Paclitaxel)
Active, not recruiting
- Ovarian Cancer
- Pembrolizumab
- +2 more
-
Milwaukee, WisconsinMedical College of Wisconsin and Froedtert Hospital
Apr 7, 2022
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial
Recruiting
- Fallopian Tube Endometrioid Adenocarcinoma
- +32 more
- Carboplatin
- +6 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 16, 2022
Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor, Refractory Ovarian Carcinoma Trial in Houston (TRPV6 Calcium
Recruiting
- Advanced Malignant Solid Neoplasm
- +22 more
- TRPV6 Calcium Channel Inhibitor SOR-C13
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in
Recruiting
- Advanced Pancreatic Carcinoma
- +27 more
- Biopsy
- Talazoparib
-
Gainesville, Florida
- +3 more
Jan 3, 2023
Stage III Ovarian Carcinoma, Stage IV Ovarian Carcinoma, Fallopian Tube Carcinoma Trial in United States (AVOVA-1, MC)
Active, not recruiting
- Stage III Ovarian Carcinoma
- +3 more
- AVOVA-1
- MC
-
Burbank, California
- +5 more
Apr 21, 2022
Clinical Stage IV Gastric Cancer AJCC v8, Clinical Stage IVA Gastric Cancer AJCC v8, Clinical Stage IVB Gastric Cancer AJCC v8
Recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +26 more
- Biopsy
- +10 more
-
Duarte, California
- +2 more
Jan 25, 2023
Stage II Fallopian Tube Cancer AJCC v8, Stage II Ovarian Cancer AJCC v8, Stage II Primary Peritoneal Cancer AJCC v8 Trial in
Not yet recruiting
- Stage II Fallopian Tube Cancer AJCC v8
- +33 more
- Alpha-type-1 Polarized Dendritic Cells
- Autologous Natural Killer Cell-like CTLs
-
Buffalo, New YorkRoswell Park Cancer Institute
Apr 1, 2022
Among Reproductive Age Gynecological and Breast Cancer
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +29 more
- Healthcare Activity
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2022
Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in
Not yet recruiting
- Advanced Biliary Tract Carcinoma
- +32 more
- Biospecimen Collection
- +6 more
-
Chicago, IllinoisNorthwestern University
Feb 6, 2023
Stage III Fallopian Tube Cancer, Stage III Ovarian Cancer, Stage III Primary Peritoneal Cancer Trial in Seattle (drug,
Terminated
- Stage III Fallopian Tube Cancer
- +14 more
- Carboplatin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 17, 2021
Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage I Ovarian Cancer Trial in Buffalo (procedure, drug, other)
Completed
- Fallopian Tube Carcinoma
- +14 more
- Diagnostic Microscopy
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 5, 2021
Ovarian Cancer Trial in United States (Vigil™)
Active, not recruiting
- Ovarian Cancer
- Vigil™
-
West Palm Beach, Florida
- +5 more
Feb 9, 2022
Collecting Blood Samples From and Without Cancer to Evaluate
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +61 more
- Questionnaire Administration
- Biospecimen Collection
- (no location specified)
Apr 12, 2022
Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Dallas (Vigil™ Vaccine, Bevacizumab)
Completed
- Stage III Ovarian Cancer
- Stage IV Ovarian Cancer
- Vigil™ Vaccine
- Bevacizumab
-
Dallas, TexasMary Crowley Cancer Research Centers
Oct 15, 2021